Half the respondents to a recent survey are aware of what pneumococcal disease is, but less than one-third were vaccinated against the condition. The poll, conducted by the Asthma and Allergy Foundation of America (AAFA), revealed a significant proportion of at-risk respondents were not immunized...

Patients with gout will soon have a new treatment option available in pharmacies following the US Food and Drug Administration's (FDA) approval of Duzallo (allopurinol, lesinurad). The once-daily oral medicine was developed by Ironwood Pharmaceuticals and is indicated for the treatment of...

More than six out of ten (61%) Americans get a flu vaccine each year or plan to get one this year, two percentage points higher than last year, according to a recent survey conducted on behalf of CVS Health. Seniors aged 65 and above were more likely to get immunization than younger people, with 76...

The US Food and Drug Administration (FDA) has announced a meeting with the Pediatric Advisory Committee to evaluate the use of prescription medication containing opioids when treating coughs in children. A statement by FDA Commissioner Scott Gottlieb, MD, highlighted the potential risks of these...

Adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) have a new targeted treatment option, following the US Food and Drug Administration's (FDA) approval of Besponsa (inotuzumab ozogamicin). The drug, developed by Pfizer, was granted Priority Review,...

A new treatment option for patients with amyotrophic lateral sclerosis (ALS) is now available in US pharmacies for the first time in 22 years. Radicava (edavarone), developed and manufactured by Mitsubishi Tanabe Pharma America, was approved by the US Food and Drug Administration (FDA) in May 2017....

Defects in dropper markings have led Amneal Pharmaceuticals to announce a voluntary recall of 13 lots of Lorazepam Oral Concentrate USP 2mg/ml. A consumer report drew the generic drug manufacturer's attention to the issue with the dosing dropper, which is supplied to Amneal by a third party. Some...

All liquid products manufactured by PharmaTech have been recalled due to the risk of Burkholderia cepacia contamination. The US Food and Drug Administration (FDA) announced the voluntary recall of liquids distributed by Leader Brand, Major Pharmaceuticals and Rugby Laboratories, including various...

The number of prescriptions filled in the United States has risen from 2.4 billion 1997 to 4.4 billion in 2016, according to figures from Quintiles IMS. With a recent Consumer Reports survey showing more than half of Americans regularly take prescription medication, the need for organized and safe...

Vyxeos (daunorubicin and cytarabine) has been approved by the US Food and Drug Administration (FDA). It is the first treatment approved for patients with certain types of high-risk acute myeloid leukemia (AML). The drug, developed by Jazz Pharmaceuticals, is a fixed combination of two chemotherapy...

The US Food and Drug Administration (FDA) has released its latest guidelines for the development of generic drugs and has requested feedback and comments on its guidance. Recently, the FDA has taken steps to increase the number of generic drugs available in the US and is on track to make a record...

Modern medicine and prescription drugs provide vital treatment and cures for a host of ailments and diseases, but in some cases, simple lifestyle changes may alleviate symptoms and reduce the risk of conditions worsening or recurring. A recent Consumer Reports survey revealed more than one-third...

Pharmacists have always been on the frontline of healthcare, providing medication and guidance to millions of American patients, and functioning as the first port of call for many in search of treatment and clinical advice. BASE10 is the latest innovation in precision medicine, providing patients...

DNA testing is one of the most exciting new developments in healthcare, and recent advances put this important health data directly in the hands of users. BASE10 is an exciting new product providing patients with valuable insights into their unique genetics, empowering them to make informed...

The US Food and Drug Administration (FDA) approved the hepatitis C virus (HCV) treatment Mavyret (glecaprevir, pibrentasvir), granting biopharmaceutical firm AbbVie Breakthrough Therapy Designation and Priority Review for the treatment of GT1 HCV patients not cured with prior direct-acting...

The drug Actemra (tocilizumab) is a more effective treatment for giant cell arteritis than steroids, a recent study has shown. The results of the trial published in the New England Journal of Medicine (NEJM) revealed more than half (56 percent) of patients treated weekly with Actemra saw sustained...

Most of us have taken antibiotics at some point in our lives, whether to combat acne, conjunctivitis, a urinary tract infection (UTI) or one of the many other ailments physicians use antibiotics to treat. However, there are a vast number of different antibiotics available, with a wide variety of...

Haegarda, the first subcutaneous preventative treatment for patients with hereditary angioedema (HAE), is now available in American pharmacies. The drug, developed by pharmaceutical giant CSL Behring, was approved for routine prophylaxis to prevent HAE attacks in adults and adolescents by the US...

The US Food and Drug Administration (FDA) has granted approval for a new self-injectable formulation of Benlysta (belimumab) developed by GlaxoSmithKline (GSK). The new product was approved for treating adult patients with active autoantibody-positive systemic lupus erythematosus (SLE). Vlad...

More than one-third of adults in the US live with either diabetes or prediabetes, a report released by the Centers for Disease Control and Prevention (CDC) has revealed. It found that in 2015 there were 30 million people with diabetes, while a further 84 million people had prediabetes. Left...